This site is still under development. Information, features, and some organizational
aspects of the data still need further work and will change as we continue building.

Fecal Occult Blood Test

Hover over a term you want explained. If you need more details, then click on the term and a new tab will open with a full details page.

What the Fecal Occult Blood Test Means

The Fecal Occult Blood Test, often called FOBT, is a screening tool that checks for hidden (occult) blood in stool samples. Blood in stool is not always visible, but its presence can be an early sign of colorectal cancer or other conditions like polyps, ulcers, or hemorrhoids. The test involves collecting a small stool sample, usually at home, which is then sent to a laboratory for analysis. There are two main types of FOBTs: the older guaiac-based test (gFOBT) that uses a chemical reaction to detect blood, and the newer fecal immunochemical test (FIT) that uses antibodies to detect blood proteins. FIT is generally more accurate and easier to use than gFOBT.

Why the Test Matters in Cancer Care

Colorectal cancer often begins as small growths called polyps that can bleed before turning into cancer. Detecting hidden blood in stool can help find cancer or precancerous polyps early, when treatment is more effective. Screening with FOBT has been shown to reduce deaths from colorectal cancer in some populations. However, the older guaiac test is less sensitive and has been largely replaced by FIT, which is now preferred by many medical groups. Early detection through these stool tests can lead to timely follow-up exams, such as colonoscopy, to find and remove polyps or treat cancer early.

What Patients Might Experience and See

Patients usually receive a kit with instructions to collect a small stool sample at home. The sample is placed in a special container or on a card and mailed or delivered to a lab. Results come back as negative (no blood found) or positive (blood detected). A positive result does not mean cancer for sure—it can also be caused by other conditions like hemorrhoids or ulcers. If blood is found, doctors usually recommend a colonoscopy to look inside the colon and rectum for the source of bleeding. It is important to understand that a single stool test done during a digital rectal exam (DRE) in a doctor’s office is not enough for reliable screening, as it misses many cases of colorectal cancer.

Common Confusions and Related Terms

FOBT may appear under different names, including guaiac fecal occult blood test (gFOBT) and fecal immunochemical test (FIT). FIT is also called iFOBT, immunochemical fecal occult blood test, or immunoassay fecal occult blood test. These tests differ in how they detect blood and their accuracy. The older gFOBT requires dietary restrictions before testing and is less sensitive, while FIT is more specific and does not require diet changes. The digital rectal examination (DRE) is sometimes used to collect a stool sample for FOBT in the office, but this method is not recommended for colorectal cancer screening due to low sensitivity.

What the Test Does Not Automatically Mean

A positive FOBT or FIT result does not confirm colorectal cancer. It only means blood was found in the stool, which can come from many causes, including non-cancerous conditions. Similarly, a negative test lowers the chance of cancer but does not guarantee its absence. These tests are screening tools, not diagnostic tests. If blood is detected, further testing like colonoscopy is needed to find the cause.

Questions to Ask Your Care Team

If your doctor recommends a fecal occult blood test, you might ask why this test is suggested, how to collect the sample properly, and what the results could mean for you. If a stool sample is taken during a digital rectal exam, ask if additional stool tests or screenings are needed. It is also helpful to ask about follow-up steps if the test is positive and how often you should be screened based on your age and risk factors.

Understanding the Test in Context

FOBT and FIT are part of a range of colorectal cancer screening options, including colonoscopy and flexible sigmoidoscopy. Screening guidelines often recommend starting regular testing at age 45 or 50 for average-risk adults. The choice of test depends on personal risk, preferences, and access. It is important to view FOBT or FIT results as one piece of information within a broader screening plan.

Safety and Next Steps

This information is educational and does not replace personalized medical advice. If you have questions about fecal occult blood testing or colorectal cancer screening, the best next step is to discuss them openly with your healthcare provider. They can help you understand what tests are appropriate for your situation and what to do based on your results.

Sources

Public source information used for this glossary entry includes: